BACKGROUND: The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early symptoms of metabolic syndrome is hypertriglyceridemia. We examined the gender differences between various metabolic factors related to insulin resistance in elderly non-diabetic men and postmenopausal women of comparable age suffering from hypertriglyceridemia, and compared them with healthy subjects of equal age. RESULTS: The indexes of insulin resistance HOMA IR and QUICKI were significantly higher in both hyperlipemic men and women than in controls; 95% confidence limits of hyperlipemic subjects did not overlap with controls. In both normolipemic and hyperlipemic men and women serum leptin correlated significantly with insulin resistance, while HDL-cholesterol correlated inversely with HOMA-IR only in women (both normo- and hyperlipemic), and serum tumor necrosis factor alpha (TNFalpha) only in hyperlipemic women. According to results of multiple regression analysis with HOMA-IR as a dependent variable, leptin played a significant role in determining insulin resistance in both genders, but--aside from leptin--triglycerides, TNFalpha and decreased HDL-cholesterol were significant determinants in women, while body mass index and decreased HDL-cholesterol were significant determinants in men. The coefficient of determination (R2) of HOMA IR by above mentioned metabolic variables was in women above 60%, in men only about 40%. CONCLUSION: The significant role of serum leptin in determination of insulin resistance in both elderly men and postmenopausal women of equal age was confirmed. However, the study also revealed significant gender differences : in women a strong influence of triglycerides, TNFalpha and decreased HDL-cholesterol, in men only a mild role of BMI and decreased HDL-cholesterol.

Institute of Physiology Faculty of Medicine Palacký University Olomouc Czech Republic

Zobrazit více v PubMed

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356–359. doi: 10.1001/jama.287.3.356. PubMed DOI

Isomaa B, Almgren P, Tuomi T, Forsén B, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. PubMed

Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1596–1607. PubMed

Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100:1166–1173. PubMed PMC

Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039–2044. PubMed

Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch intern Med. 2002;162:82–89. doi: 10.1001/archinte.162.1.82. PubMed DOI

Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1995;1:1155–1161. PubMed

Hickey NS, Israel RG, Gardiner SN, et al. Gender differences in serum leptin levels in humans. Biochem Mol Med. 1996;59:1–6. doi: 10.1006/bmme.1996.0056. PubMed DOI

Haffner SM, Gingerich RL, Miettinen H, Stern MP. Leptin concentrations in relation to overall adiposity and regional fat distribution in Mexican Americans. Int J Obes. 1996;20:904–908. PubMed

Zimmet P, Hodge A, Nicholson M, Straten M, De Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross sectional study. BMJ. 1996;313:965–969. PubMed PMC

Harmelen VV, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnquist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913–917. PubMed

Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997;46:342–347. PubMed

Tai ES, Lau TN, Ho SC, Fok ACK, Tan CE. Body fat distribution and cardiovascular risk in normal weight women. Association with insulin resistance, lipids and plasma leptin. Intern J of Obesity. 2000;24:751–757. doi: 10.1038/sj.ijo.0801220. PubMed DOI

Hotamisligil GS, Arner P, Caro JF, Atkinson L, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–2415. PubMed PMC

Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111–2119. PubMed PMC

Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11:212–217. doi: 10.1016/S1043-2760(00)00272-1. PubMed DOI

Couillard C, Meuriége P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Després J-P. Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia. 1997;40:1178–1184. doi: 10.1007/s001250050804. PubMed DOI

Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J clin Endocrinol Metab. 1997;82:1293–1300. PubMed

Erikkson J, Valle T, LindströM j, Haffner S, Louhernta A, Uusitupa M, Tuomilehto J. Leptin concentrations and theit relation to body fat distribution and weight loss – A prospective study in individuals with impaired glucose tolerance. Horm Metab Res. 1999;31:616–619. PubMed

Hattori A, Uenura K, Miura H, Ueda M, Tamaya N, Iwata F, Muraguchi M, Ohmoto Y, Iguchi A. Gender-related diferrence in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic and non-diabetic subjects. Endocrine journal (Japan) 2000;47:615–621. PubMed

Doucet E, St-Pierre S, Alméras N, Mauriége P, Després J-P, Richard D, Bouchard C, Tremblay A. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: Evidence from both a cross-sectional and intervention study. J Clin Endocrinol Metab. 2000;85:4231–4237. PubMed

Baumgartner RN, Ross RR, Waters DL, Brooks WM, Morley JE, Montoya GD, Garry PJ. Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes. Obesity Research. 1999;7:141–149. PubMed

Ruige JB, Dekker JM, Blum WF, Stehouver CD, Nijpels G, Mooy J, Kostense PJ, Bouter LM, Heine RJ. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care. 1999;22:1097–1104. PubMed

Marshall JA, Grunwald GK, Donahoo WT, Scarbro S, Shetterly SM. Percent body fat and lean mass explain the gender difference in leptin: Analysis and interpretation of leptin in Hispanic and non-Hispanic whitw adults. Obesity Research. 2000;8:543–552. PubMed

Assmann G, Carmena R, Cullen P, Fruchart J-C, Jossa F, Lewis B, Mancini M, Paoletti R. Coronary heart disease: Reducing the risk. Nutrition, metabolism and cardiovascular disease. 1998;8:205–271.

Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Galagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996;81:3424–3427. PubMed

Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nature Med. 1996;2:949–950. PubMed

Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Current Opinion in Lipidology. 1997;8:159–166. PubMed

Martin G, Schoonjans K, Staels B, Auwerx J. PPAR activators improve glucose homeostasis by changing fatty acid partitioning. In: Jacocot B, Mathé D, Frichart J-C, editor. Atherosclerosis XI. Elsevier Science, Singapore; 1998. pp. 35–47. PubMed

Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3159–3163. PubMed

Erkkilä AT, Närvänen O, Lehto S, Uusitupa MIJ, Ylä-Herttuala S. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:204–209. PubMed

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–419. PubMed

Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study. Diabetes Care. 1997;20:1087–1092. PubMed

Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check Index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410. PubMed

Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L. Detection of insulin resistance by simple quantitative sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002;87:144–147. PubMed

Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationship in obese and nonobese humans. Diabetes. 1996;45:695–698. PubMed

Considin RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–295. doi: 10.1056/NEJM199602013340503. PubMed DOI

Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol. 1996;271:623–630. PubMed

Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin level: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab. 1996;81:4433–4438. PubMed

Sumner AE, Falkner B, Kushner H, Considine RV. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans. Obesity Research. 1998;6:128–133. PubMed

Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE. The concurrent accumulation of intra-abdominal and subcutanous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes. 2002;51:1005–1015. PubMed

Mendoza-Núnez VM, García-Sanchéz A, Sánchéz-Rodrigéz M, Galván-Duarte RE, Fonseca-Yerena ME. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obesity Research. 2002;10:253–259. PubMed

Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91. PubMed

Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science. 1996;259:87–91. PubMed

Hotamisligil GS. Mechanisms of TNFα-induced insulin resistance. J Exp Clin Endocrinol Diabetes. 1999;107:119–125. PubMed

Stephens JM, Lee JL, Pilch PF. Tumor necrosis factor-alpha induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT 4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem. 1997;272:971–976. doi: 10.1074/jbc.272.2.971. PubMed DOI

Hoffstedt J, Eriksson P, Hellström L, Rössner S, Rydén M, Arner P. Excessive fat accumulation is associated with the TNFα-308 G/A promoter polymorphism in women but not in men. Diabetologia. 2000;43:117–120. doi: 10.1007/s001250050015. PubMed DOI

Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetes mellitus. Diabetes Metab. 2000;26:178–182. PubMed

Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355–362. PubMed

Schlame M, Hostetler KY. Cardiolipin synthase from mammalian mitochondria. Biochimica and Biophysica Acta. 1997;1348:207–213. doi: 10.1016/S0005-2760(97)00119-7. PubMed DOI

Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus. 1998;7:S132–S134. PubMed

Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ, Glatz JF. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol. 1998;275:E47l–E478. PubMed

Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol. 1998;274:E210–E217. PubMed